| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2024 | ASRT Assertio Holdings, Inc. | Vacirca Jeff L | Director | Buy | 10,000 | $1.11 | $11,100.00 | +7.1% | +18.5% | -39.6% | |
| Jun 11, 2024 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 2,510 | $21.47 | $53,889.70 | -1.6% | -36.6% | +161.2% | |
| Jun 11, 2024 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Commercial Officer | Sell | 392,240 | $22.05 | $8,649,194.31 | -52.6% | -36.6% | +161.2% | |
| Jun 10, 2024 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 75,510 | $860.78 | $64,997,274.12 | - | +5.0% | -6.7% | |
| Jun 10, 2024 | CGC Canopy Growth Corp | Mongeau Luc79 | Director | Sell | 3,745 | $9.94 | $37,225.30 | -17.8% | -33.4% | -79.4% | |
| Jun 10, 2024 | IRWD Ironwood Pharmaceuticals Inc | McHugh Julie55 | Director | Sell | 22,766 | $6.29 | $143,198.14 | -14.0% | -39.1% | -87.8% | |
| Jun 10, 2024 | CGC Canopy Growth Corp | Hong Judy Eun Joo65 | Chief Financial Officer | Sell | 45 | $9.94 | $447.30 | - | -33.4% | -79.4% | |
| Jun 10, 2024 | CGC Canopy Growth Corp | Kruh Willy74 | Director | Sell | 3,738 | $9.94 | $37,155.72 | -17.8% | -33.4% | -79.4% | |
| Jun 10, 2024 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 3,000 | $41.40 | $124,200.00 | -3.7% | +7.0% | -35.4% | |
| Jun 10, 2024 | CGC Canopy Growth Corp | Lazzarato David Angelo75 | Director | Sell | 3,707 | $9.94 | $36,847.58 | -9.6% | -33.4% | -79.4% | |
| Jun 10, 2024 | CGC Canopy Growth Corp | Klein David Eric55 | Chief Executive Officer | Sell | 1,779 | $9.94 | $17,683.26 | -0.4% | -33.4% | -79.4% | |
| Jun 10, 2024 | CGC Canopy Growth Corp | Yanofsky Theresa75 | Director | Sell | 3,692 | $9.94 | $36,698.48 | -11.6% | -33.4% | -79.4% | |
| Jun 10, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $275.54 | $1,983,862.05 | -31.1% | +26.7% | +2.2% | |
| Jun 7, 2024 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 139,490 | $852.29 | $118,886,587.05 | - | +7.4% | -9.4% | |
| Jun 7, 2024 | IRWD Ironwood Pharmaceuticals Inc | Moukheibir Catherine82 | Director | Sell | 80,000 | $6.47 | $517,693.50 | -37.6% | -26.6% | -90.4% | |
| Jun 6, 2024 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 179,617 | $837.82 | $150,485,877.68 | - | +13.0% | -8.1% | |
| Jun 6, 2024 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 98,635 | $21.42 | $2,113,225.28 | -40.2% | -32.3% | +161.1% | |
| Jun 6, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $277.24 | $1,996,118.62 | -25.9% | +27.8% | +17.9% | |
| Jun 6, 2024 | EOLS Evolus, Inc. | Moatazedi David67 | See Remarks | Sell | 471,432 | $12.74 | $6,005,627.99 | -22.8% | +24.3% | -19.0% | |
| Jun 5, 2024 | ASRT Assertio Holdings, Inc. | Mason Heather L49 | Interim Executive Officer | Buy | 25,000 | $0.97 | $24,250.00 | +13.3% | +11.0% | -34.8% | |
| Jun 5, 2024 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 20,383 | $836.32 | $17,046,672.82 | - | +15.0% | -7.9% | |
| Jun 5, 2024 | ANIP Ani Pharmaceuticals Inc | Gutwerg Ori47 | SVP, Generics | Sell | 2,985 | $67.00 | $199,995.00 | -3.7% | -5.9% | -10.6% | |
| Jun 5, 2024 | BTAI Bioxcel Therapeutics, Inc. | Mehta Vimal92 | CEO And President | Sell | 1,427,494 | $0.28 | $405,135.01 | -5.7% | -62.0% | -94.1% | |
| Jun 5, 2024 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 105,756 | $20.54 | $2,171,786.89 | -3.1% | -33.3% | +142.6% | |
| Jun 4, 2024 | ANIP Ani Pharmaceuticals Inc | Carey Stephen P.55 | SVP &CFO | Sell | 5,000 | $63.58 | $317,900.00 | -3.0% | -2.7% | -6.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.